Ind-Swift Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.80×	0.84×	0.97×	0.72×	0.55×
	1.46×	3.38×	−5.88×	2.90×	0.50×
	9.5%	2.3%	−7.8%	15.7%	14.2%
	0.41×	0.41×	0.43×	0.86×	0.66×
	1.20×	1.21×	1.23×	1.25×	2.67×
	5.5%	3.2%	23.5%	35.4%	7.0%
	3.2%	3.2%	23.8%	52.2%	7.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INDSWFTLAB₹409.80

Ind-Swift Laboratories Limited

· Pharma & Health

₹ CrorePeersSMSPHARMA SOLARA DCAL HIKAL UNICHEMLAB GUFICBIO PANACEABIO RPGLIFEMcap ₹3,559 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.55	0.72	0.97	0.84	0.80
Interest Burden (Pretax/EBIT) ×	0.50	2.90	-5.88	3.38	1.46
EBIT Margin %	14.23	15.68	-7.81	2.26	9.48
Asset Turnover ×	0.66	0.86	0.43	0.41	0.41
Financial Leverage (Assets/Equity) ×	2.67	1.25	1.23	1.21	1.20
ROE (5-step product, year-end total equity) %	6.96	35.39	23.51	3.20	5.47
ROE (owners' profit / average owners' equity) %	6.98	52.24	23.80	3.24	3.24

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.